Axel Dignass retweeted
🌟 Latest work in @IBDJournal
@FernandoMagro6 @silvio_silvio75 @AxelDignass @MMEstevinho
@GEDII_IBD
Impact of Crohn’s Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis academic.oup.com/ibdjournal/…
Axel Dignass retweeted
I gave a talk on #networks and #IBD at #GETECCU22 and missed this incredible paper. It is rather interesting @geteccu #somosGeteccu I will havt to review Proud to appear in some graphs with giants and friends @JeanFredericCo1 @AxelDignass @silvio_silvio75 @jp_gisbert @ibddoctor
Thanks for highlighting,@ManasiAgrawalMD.Interesting approach,however, feel that several esteemed colleagues may be missed by the "algorithms". Humbled to see my name popping up in one analysis next to @IBD_FloMD @fgomollon @ibdseb @DignassAxel @silvio_silvio75 @PeyrinBiroulet...
Axel Dignass retweeted
Her final slide is a good summary: coming back to the physician-patient relationship, the essence of #medicine @my_ueg @AxelDignass @charlie_lees @DCharabaty @Bealoquebea @yzabanaa @sicilia_beatriz @maria_chs @geteccu #SomosGeteccu @ACCU_Espana xitter.gq/fgomollon/status/15791…
#Profile #OSM #immunogenicity #tightmonitoring #calm #calprotectin #extraintestinalmanifestations #adapt #sparetrial #stopping #biocycle some key words from Britta Siegmund talk at #UEG22 @my_ueg #Somosgeteccu
Axel Dignass retweeted
Indeed a story of success!
#UEGWeek a story of success
✅ 🇩🇪 🔝participants
✅ 1️⃣0️⃣3️⃣4️⃣7️⃣ Total participants
✅ 2️⃣9️⃣3️⃣9️⃣ abstracts
🙏 @hlcortezpinto @d_mstl @my_ueg
Axel Dignass retweeted
You can find the executive summary of the UEG White Book 2.0 on the September issue of the UEG Journal. If you are attending UEG Week 2022, this is in your bag! @Mat_OLLIVIER @my_ueg @UEGJournal onlinelibrary.wiley.com/doi/…
Axel Dignass retweeted
We apologise for any miscommunication due to the tweet character length. Please read the full statement: https://xitter.gq/t.co/iFbzxWzu0e. Our deepest sympathy goes out to Ukraine & we stand firmly against this war. We have donated to ICRC to help those in Ukraine who are suffering.
Axel Dignass retweeted
Many exciting state-of-the-art reviews on various important topics in current #IBD care. Find out now in a special @AGA_Gastro edition on IBD! @DrAilsaHart @IBDMD @JoanaTo62523004 @ryanungaro @JeanFredericCo1 @silvio_silvio75 @PeyrinBiroulet @IBD_MB @IBD_FloMD @guthealthmd
Axel Dignass retweeted
Excited to see #PIANO make the @AGA_Gastro editors top ten high impact articles of 2021. It took a village… @MLongMD @SunandaKaneMD -Clinical_122921 contentsharing.net/actions/e…
Axel Dignass retweeted
European Guideline on IgG4‐related digestive disease
@uegjournal @my_ueg
onlinelibrary.wiley.com/doi/…
Axel Dignass retweeted
Fantastic start of IOIBD meeting in Bordeaux: Nadine Cerf from Necker on lessons from Mendelian diseases
Axel Dignass retweeted
EIC of @UEGJournal is taking care of his CO-Editors anytime and everywhere 😀@joostphdrenth
Replying to @AlexMeining
@AlexMeining in the #UEGWEEK2021 virtual meeting ✅ very focused ✅ on top of the game ✅ proud to have Prof Meining as @UEGJournal Editor on #endoscopy @lelecapurso @AlexandreNuzzo @RC_Fitzgerald @MarcusHollenba1
Axel Dignass retweeted
Get ready for more #InjestTheBest
IBD prediction and prognosis-can we tell the future of our patients?..how?..watch the session and see..Hall 1, 16:30 CEST #UEGWeek
Axel Dignass retweeted
…but multiple obstacles have to be overcome in #IBD associated fibrosis to allow testing of anti-fibrotic medications. @MRegueiroMD @JPAchkarMD @RobertoSimonsMD @IBDMD @IBD_MB
Axel Dignass retweeted
Replying to @my_ueg
Thank you @MarkusPeck1 Our Public affairs advocacy work aims for digestive diseases to be recognized as a major group of health conditions @PatriziaBurra @hlcortezpinto @AxelDignass
Important message for our #IBD patients: #exercise is useful and does not harm in #Crohn‘s disease @UEGJ #UEGJ
Proof of principle study by @AxelDignass shows that moderate muscle training is possible in #crohns disease and leads to better #qualityoflife. Great work now out in @UEGJournal @FernandoMagro6 @ibdtweets @Y_ECCO_IBD @bverstockt @colitisandme journals.sagepub.com/doi/ful…
Axel Dignass retweeted
Fatigue prevalent among ibd patients. Think about it/ identify/ evaluate/ assess the strategy/ Treat the different correlated factors @AxelDignass #ECCO20 #ECCO2020 #ecco
Axel Dignass retweeted
Replying to @AxelDignass



































